How NDRG proteins help cells cope with low oxygen

NDRGs as mediators of hypoxia adaptation

NIH-funded research University of Maryland Baltimore County · NIH-11371409

This project looks at whether NDRG proteins protect cells from damage when oxygen levels fall, which could matter for people with stroke, acute kidney injury, or sickle cell crises.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore County NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-11371409 on NIH RePORTER

What this research studies

From a patient perspective, the team studies a group of proteins called NDRGs to learn how cells survive when oxygen is low and when oxygen returns. They will use lab models—cells and animals—to mimic low-oxygen and re-oxygenation events, measure cell energy and harmful oxygen molecules, and change NDRG levels to see the effects. Findings will be compared to known features of human conditions like acute kidney injury and stroke to identify pathways that might be targeted. The overall aim is to find biological switches that could one day be turned into treatments to protect organs from oxygen-related damage.

Who could benefit from this research

Good fit: People affected by oxygen-related injuries—for example recent stroke victims, patients recovering from acute kidney injury, or individuals with sickle cell crises—would be the kinds of patients who might benefit from future trials based on this work.

Not a fit: Patients whose conditions do not involve oxygen fluctuations or hypoxic injury are unlikely to see direct benefit from this specific line of research.

Why it matters

Potential benefit: If successful, this work could point to new ways to protect tissues and reduce damage after low-oxygen events such as stroke or acute kidney injury.

How similar studies have performed: Prior laboratory studies indicate NDRG proteins can help cells survive low-oxygen in cell and animal models, but translating these findings into human therapies remains largely untested.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.